| Literature DB >> 18023356 |
Yvette L Kasamon1, Richard F Ambinder.
Abstract
Multiple immune evasion strategies characterize the pathobiology of Hodgkin's lymphoma. These must be considered when developing and testing immunotherapeutic approaches for this disease. The clinical experience with adoptive immunotherapy of Epstein-Barr virus positive tumors, and with monoclonal antibodies directed against CD30, CD20, and other antigens, is herein reviewed.Entities:
Mesh：
Substances：
Year: 2007 PMID： 18023356 PMCID： PMC5792053 DOI： 10.1016/j.critrevonc.2007.10.001
Source DB: PubMed Journal: Crit Rev Oncol Hematol ISSN： 1040-8428 Impact factor: 6.312